Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 2 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Sarcoma 2 Neoplasm Metastasis 1 Colorectal Neoplasms 1 Cervical Cancer Susceptible Population Classification 1

Interventions

Irinotecan 11 Oxaliplatin 8 Cetuximab 7 Fluorouracil 6 Leucovorin 5 Bevacizumab 5 Standard of Care 4 S 1 (combination) 4 Capecitabine 4 trifluridine tipiracil drug combination 2 tislelizumab 2 apatinib 2 Propranolol 2 Preoperative Exercise 2 Panitumumab 2 Levoleucovorin 2 Folfox protocol 2 Etodolac 2 Endoscopic Mucosal Resection 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 trebananib 1 regorafenib 1 envafolimab 1 Trifluridine 1 Thalidomide 1 Surveys and Questionnaires 1 Occult Blood 1 Neoadjuvant Therapy 1 Moxibustion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Colorectal Neoplasms × Base Sequence × Clear all

NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡